The 21st National Cancer Congress and the Achievements of Our Memorial-Medstar Antalya Cancer Center Team

The "21st National Cancer Congress," our country's longest-established congress in this field, was held in Antalya between 22-26 April 2015, hosted by the Turkish Medical Oncology, Turkish Pediatric Oncology Group, and Turkish Radiation Oncology associations. Expert scientists from throughout our country and the world attended.
Between 22-26 April 2015 in Antalya, at the 21st National Cancer Congress organized by the Pediatric Oncology, Radiation Oncology, and Medical Oncology associations, we participated with a total of (despite having no submissions from our Pediatric Oncology or Radiation Oncology departments) 5 oral presentations among 33 abstracts. At the congress, attended by 1600 participants, we organized a full-day nurse education course for oncology nurses with the highest attendance. Among institutions attending, including universities, we ranked 7th nationally for abstract submissions and 1st among private institutions.
Our study planned by Prof. Dr. Akın Yıldız, titled "Can the Role of PET/CT in Rectal Cancer Nodal Staging Be Improved Through Metabolic and Morphological Assessment?", receiving the Poster Presentation Award crowned our efforts.
As Memorial-Medstar Antalya Oncology Center, alongside bringing all cancer diagnosis and treatment specialties under one roof and applying international-standard technologies simultaneously with the rest of the world, we place great importance on scientific research, and our scientific work will continue to increase.
Our award-winning study can be summarized as follows:
"Assessing lymph node metastases in preoperative rectal cancer staging is important for deciding on preoperative tumor-reducing (neoadjuvant) chemoradiotherapy. Locoregional recurrence rates are also higher in node-positive patients. Imaging methods lack sufficient sensitivity for nodal assessment. No optimal size criterion has been established for imaging, but histopathological examination can detect metastases in nodes smaller than 3 mm at a rate of % 28. Computed tomography (CT) has low and variable sensitivity in nodal assessment. Low sensitivity in endoscopic ultrasonography (EUS) and magnetic resonance imaging (MRI) results in understaging. PET/CT is used in rectal cancer to assess distant metastases. Our study aimed to improve diagnostic accuracy in local assessment through diagnostic-dose, contrast-enhanced PET/CT.
In conclusion: In a meta-analysis by Brush and colleagues on nodal assessment in rectal cancer, PET/CT had low sensitivity (%28) and high specificity (%92). However, recent studies report higher sensitivities. Our study found that adding multiplanar CT assessment to PET/CT nodal evaluation increased sensitivity but decreased specificity. On nodal morphological examination, irregular contours and heterogeneity identify metastatic lymph nodes but can also occur in reactive nodes. Size assessment was not used as a criterion because there is no accepted optimal threshold. Because of factors such as tumor biology and technical resolution limits, PET/CT needs evaluation in larger case series for nodal assessment.
Although performing and interpreting PET/CT with optimal technique contributes to nodal staging, morphological assessment was found to reduce specificity."
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.